Abstract
Pretransplant screening of potential recipient patient sera to determine the level of allosensitization to class I HLA antigens has traditionally been done as an aid in the management of transplant waiting lists. A soluble HLA (sHLA) ELISA was developed as an alternative to lymphocytotoxicity for anti-HLA antibody screening. This ELISA was used for the detection of anti-HLA class I IgG, IgGl, IgG2, IgG3, IgG4, and IgM antibodies and used to analyze the correlation of pretransplant allosensitization and post transplant rejection episodes in renal allograft recipients. ELISA plates were coated with 46 different sHLA preparations representing 40 different HLA class I antigens. After incubation with a serum specimen, bound antibodies were detected with a peroxidase conjugated antibody. Serum specimens from 158 microlymphocytotoxicity positive patients were analyzed. Eighty-four patients had experienced one or more rejection episodes within twelve months post trans-plantation. One hundred two patients were tested positive by ELISA (total IgG %PRA > 10%). A strong correlation between first year rejection and ELISA detected anti-HLA class I IgG (p=0.0004) and IgG1 (p<0.0001) was observed. The predictive value for IgG was 64% and for IgG1, 73% demonstrating that ELISA results allow the identification of patients at high risk to reject the transplanted kidney. Presence of anti-HLA class I IgG2, IgG3, IgG4 or IgM was not predictive of first year rejection episodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hopkins KA: Basic microlymphocytotoxicity test. In: Zachary AA, Terisi GA (eds): ASHI laboratory manual. 2d ed. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1990.
Zmijewski C: Detection and Identification of HLA Antibodies. In: Zachary AA, Terisi GA (eds): ASHI laboratory manual. 2d ed. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1990.
Noreen HJ: Crossmatch test. In: Zachary AA, Terisi GA (eds) ASHI laboratory manual. 2d ed: Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1990.
Buelow R, Mercier I, Glanville L, Regan J, Ellingson L, Janda G, Claas F, Colombe B, Gelder F, Grosse-Wilde H, Orosz C, Westhoff U, Voegeler U, Monteiro F, Pouletty P: Detection of panel reactive anti-HLA class I antibodies by ELISA or lymphocytotoxicity: Results of a blinded, controlled multicenter study. Human Immunol 44: 1, 1995
Hopkins KA, Maguire MG, Fink NE, Bias WB: Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collabo¬rative Corneal Transplantation Studies Group, Baltimore, MD. Human Immunol 33: 122, 1992
Marrari M, Duquesnoy R: Progress Report on the ASHI/CAP Proficiency Survey Program in Histocom¬patibility Testing. I. HLA-A, B, C Typing, Antibody Screening, and Lymphocytotoxicity Crossmatching. Human Immunol 39: 87, 1994
Albert E: Report on the tissue typers meeting at Eurotransplant on Friday, September 27, 1991. Eurotransplant Newsletter 89: 11, 1993
Doxiadis IN, Schreuder GMTh, Claas FHJ: ET quality control testing of tissue typing, donor retyping, crossmatching and serum screening. Eurotransplant Newsletter 98: 11, 1988
Kerman RH, Van Buren CT Lewis RM et al.: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Transplant Proc 3 (suppl 3): 264, 1988
Koka P, Cecka JM: Sensitization and crossmatching in renal transplants. In: Terasaki GA (ed): Clinical Transplants 1989, UCLA Tissue Typing Lab Pubi: 379, 1990
Terasaki Pi, Cicciarelli J: Sensitization and its role in transplantation. In: Cerilli J (ed): Organ Transplan¬tation and Replacement, Philadelphia Lippincott Pubi: 197 1988
Doxiadis I, Westhoff U, Grosse-Wilde H: Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59: 449, 1989
Shimizu B, Sra K, Ferrone S., Pouletty P: sHLA-STAT_ class I, an ELISA for quantification of HLA antigens in serum. Human Immunol 32: 289, 1991
Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizy R, Grosse-Wilde H: Summary Report from the First International Workshop on Soluble HLA Antigens. Paris, August 1992. Tissue Antigens 42: 45, 1993
Pouletty P, Chang C, Atwood E, Kalil J, Ferrone S, Shimizu R, Howson W, Mazahari R, Del Villano B, Grumet C: Typing of serum soluble HLA-B27 by ELISA. Tissue Antigens 42: 14, 1993
Tierey JM, Morel C, Freidel AC, Zwahlen F, Gebuhrer L, Betuel H, Jeannet M, Mach B: Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 88: 7121, 1991
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New york
About this chapter
Cite this chapter
Regan, J. et al. (1996). Correlation of Elisa-Measured anti-HLA Class I IGG and IGG1 Antibodies and First-Year Rejection Episodes. In: Abraham, N.G., Asano, S., Brittinger, G., Maestroni, G.J.M., Shadduck, R.K. (eds) Molecular Biology of Hematopoiesis 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0391-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0391-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8031-3
Online ISBN: 978-1-4613-0391-6
eBook Packages: Springer Book Archive